GEFISTERIS 250 Mg Tablet : Uses, Dosage, Side Effects, Price, Composition and More.

GEFISTERIS 250 Mg 

Gefitinib (250mg)

GEFISTERIS 250 contains Gefitinib as the active ingredient in a 250mg dosage. This medication falls under the category of tyrosine kinase inhibitors and is commonly used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC). Here's a concise yet comprehensive guide covering its uses, dosage, price, potential side effects, composition, and more.

Uses of GEFISTERIS 250:

1. Non-Small Cell Lung Cancer (NSCLC): GEFISTERIS 250 is primarily prescribed for the treatment of NSCLC that has specific genetic mutations, such as EGFR (epidermal growth factor receptor) mutations.
2. Cancer Treatment: It works by inhibiting the activity of EGFR, a protein involved in cancer cell growth and proliferation, thereby slowing down or stopping the growth of cancer cells.

Dosage:

• The recommended dosage of GEFISTERIS 250 is typically one tablet (250mg) taken orally once daily, with or without food.
• Dosage adjustments or interruptions may be necessary based on individual response, tolerability, and the advice of healthcare providers.
• It's crucial to follow the prescribed dosage and schedule consistently for optimal treatment outcomes.

Price and Availability:

• The price of GEFISTERIS 250 can vary based on factors such as the brand, dosage strength, and location.
• It may be available in different packaging sizes, and generic versions may offer cost-effective alternatives.
• Check with pharmacies or healthcare providers for specific pricing and availability details.

Composition:

Each GEFISTERIS 250 tablet contains:

• Gefitinib (250mg): The active ingredient that inhibits EGFR tyrosine kinase activity, leading to anti-cancer effects.
• Inactive ingredients may include microcrystalline cellulose, lactose, croscarmellose sodium, magnesium stearate, and others, depending on the formulation.

Side Effects:

Common side effects associated with GEFISTERIS 250 may include:

• Diarrhea
• Skin rash or acne-like eruptions
• Nausea or vomiting
• Fatigue or weakness
• Loss of appetite

Serious side effects such as severe skin reactions, liver problems, lung inflammation, or vision changes require immediate medical attention.

Precautions

• Inform your healthcare provider about any allergies, medical conditions, or medications you are currently taking before starting GEFISTERIS 250.
• Regular monitoring of liver function, lung function, and vision may be necessary during treatment.
• Avoid grapefruit or grapefruit juice while using GEFISTERIS 250, as it may interact with the medication.
• Pregnant or breastfeeding women should discuss the risks and benefits of GEFISTERIS 250 with their healthcare provider before use.

Conclusion:

GEFISTERIS 250 (Gefitinib 250mg) is a targeted therapy medication used in the treatment of NSCLC with specific genetic mutations. Understanding its uses, dosage, potential side effects, and precautions is crucial for safe and effective cancer treatment. Consult healthcare professionals for personalized guidance and monitoring throughout the treatment journey. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW